Brief: Oncolys BioPharma says first patient enrolled into Telomelysin Phase I clinical trial

Oncolys Biopharma

07/07/2017 09:23

July 7 (Reuters) - Oncolys BioPharma Inc  4588.T   
     
     
    * Says first patient enrolled into Telomelysin Phase I 
clinical trial for esophageal cancer treatment  
     
    Source text in Japanese:https://goo.gl/bLnYm8 
    Further company coverage: 4588.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111; 
Reuters Messaging: Pingping.Li@thomsonreuters.com@reuters.net))